Delivery Order SPE2DB22D1017-SPE2DB25FG2GF
Award Date
5/9/25
Potential Completion Date
5/12/25
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humira (adalimumab) pens, a biologic medication used to treat various autoimmune conditions. The contract has a ceiling value of $9,550.39 and a period of performance through May 8, 2025. It is a firm-fixed-price contract, which indicates a predetermined price for the delivered...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humira (adalimumab) 40 mg/0.4 mL pens, a medication used to treat various autoimmune diseases. The contract has a firm fixed price of $4,518.15 and a period of performance through May 6, 2025. It is not designated as a set-aside contract, indicating open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humira Pen, a 40 mg/0.8 mL medication, with a ceiling value of $2,124.06 and a performance period ending on April 18, 2025. The contract is a firm fixed-price, non-set-aside arrangement, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) autoinjector pens. The contract has a firm fixed price of $4,941.30 and a performance period ending on April 28, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00 held by Amerisourcebergen with the DLA Troop Support Medical, which...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humira (adalimumab) 40 mg/0.4 mL prefilled pens, a biologic medication used to treat various autoimmune conditions. The contract has a firm fixed price of $2,265.90 and a performance period ending on April 28, 2025. This contract is not set aside for any specific business...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $22,542.65 and is for the delivery of Humira (adalimumab) auto-injector pens, a prescription medication used to treat various autoimmune conditions. The contract is not set aside and is a firm fixed-price delivery order, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,794.58, is for the supply of Humira (adalimumab) 40 mg/0.4 mL pens, a medication used to treat various autoimmune diseases. The contract is a firm-fixed-price delivery order, with a performance period ending on May 2, 2025. This contract is not designated as a set-aside and was...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humira (adalimumab) auto-injector pens, a biologic medication used to treat various autoimmune conditions. The contract has a firm fixed price of $1,014.65 and a period of performance through April 18, 2025. It is not designated as a set-aside contract, indicating open...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) pens. The contract has a firm fixed price of $29,441.08 and a period of performance through April 26, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) 40 mg/0.4 mL prefilled pens. The contract has a firm fixed price of $2,188.39 and a performance period through May 1, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...